Archives of Clinical Infectious Diseases

Published by: Kowsar

Seroprevalence of Brucellosis in HIV-Infected Patients in Sanandaj, Iran

Mohammad Ali Rezaee 1 , Ahmad Rashidi 1 , Mohammad Ghaedi 1 , Ali Jalili 1 , Ali Pazoki 1 , Shahoo Menbari 2 and Mohammad Reza Rahmani 1 , *
Authors Information
1 Department of Immunology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, IR Iran
2 Department of Pathology and Medical Laboratory Sciences, Faculty of Para Medicine, Kurdistan University of Medical Sciences, Sanandaj, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: April 24, 2013, 8 (2); ee16989
  • Published Online: April 17, 2013
  • Article Type: Research Article
  • Received: October 7, 2012
  • Revised: January 15, 2013
  • Accepted: February 27, 2013
  • DOI: 10.5812/archcid.16989

To Cite: Rezaee M A, Rashidi A, Ghaedi M, Jalili A, Pazoki A, et al. Seroprevalence of Brucellosis in HIV-Infected Patients in Sanandaj, Iran, Arch Clin Infect Dis. 2013 ; 8(2):ee16989. doi: 10.5812/archcid.16989.

Abstract
Copyright © 2013, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Colmenero Castillo JD, Cabrera Franquelo FP, Hernandez Marquez S, Reguera Iglesias JM, Pinedo Sanchez A, Castillo Clavero AM. [Socioeconomic effects of human brucellosis]. Rev Clin Esp. 1989; 185(9): 459-63[PubMed]
  • 2. Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med. 2005; 352(22): 2325-36[DOI][PubMed]
  • 3. Mantur BG, Biradar MS, Bidri RC, Mulimani MS, Veerappa, Kariholu P, et al. Protean clinical manifestations and diagnostic challenges of human brucellosis in adults: 16 years' experience in an endemic area. J Med Microbiol. 2006; 55: 897-903[DOI][PubMed]
  • 4. Barroso Garcia P, Rodriguez-Contreras Pelayo R, Gil Extremera B, Maldonado Martin A, Guijarro Huertas G, Martin Salguero A, et al. [Study of 1,595 brucellosis cases in the Almeria province (1972-1998) based on epidemiological data from disease reporting]. Rev Clin Esp. 2002; 202(11): 577-82[PubMed]
  • 5. Ruiz-Mesa JD, Sanchez-Gonzalez J, Reguera JM, Martin L, Lopez-Palmero S, Colmenero JD. Rose Bengal test: diagnostic yield and use for the rapid diagnosis of human brucellosis in emergency departments in endemic areas. Clin Microbiol Infect. 2005; 11(3): 221-5[DOI][PubMed]
  • 6. Al Dahouk S, Tomaso H, Nockler K, Neubauer H, Frangoulidis D. Laboratory-based diagnosis of brucellosis--a review of the literature. Part II: serological tests for brucellosis. Clin Lab. 2003; 49(11-12): 577-89[PubMed]
  • 7. Mansoor N, Abel B, Scriba TJ, Hughes J, de Kock M, Tameris M, et al. Significantly skewed memory CD8+ T cell subsets in HIV-1 infected infants during the first year of life. Clin Immunol. 2009; 130(3): 280-9[DOI][PubMed]
  • 8. Ansari AA, Pattanapanyasat K, Pereira LE. Autoimmunity and HIV/simian immunodeficiency virus infection: A two edged sword. Hepatol Res. 2007; 37 Suppl 3-95[DOI][PubMed]
  • 9. Franco MP, Mulder M, Gilman RH, Smits HL. Human brucellosis. Lancet Infect Dis. 2007; 7(12): 775-86[DOI][PubMed]
  • 10. Meyer CN, Skinhoj P, Prag J. Bacteremia in HIV-positive and AIDS patients: incidence, species distribution, risk-factors, outcome, and influence of long-term prophylactic antibiotic treatment. Scand J Infect Dis. 1994; 26(6): 635-42[PubMed]
  • 11. Zhan Y, Kelso A, Cheers C. Differential activation of <italic>Brucella</italic>-reactive CD4+ T cells by <italic>Brucella</italic> infection or immunization with antigenic extracts. Infect Immun. 1995; 63(3): 969-75[PubMed]
  • 12. Skendros P, Pappas G, Boura P. Cell-mediated immunity in human brucellosis. Microbes Infect. 2011; 13(2): 134-42[DOI][PubMed]
  • 13. El-Atrouni W, Berbari E, Temesgen Z. HIV-associated opportunistic infections. Bacterial infections. J Med Liban. 2006; 54(2): 80-3[PubMed]
  • 14. Vrioni G, Pappas G, Priavali E, Gartzonika C, Levidiotou S. An eternal microbe: <italic>Brucella</italic> DNA load persists for years after clinical cure. Clin Infect Dis. 2008; 46(12)-6[DOI][PubMed]
  • 15. Hadadi A, Rasoulinejad M, HajiAbdolbaghi M, Mohraz M, Khashayar P. Clinical profile and management of brucellosis in Tehran - Iran. Acta Clin Belg. 2009; 64(1): 11-5[PubMed]
  • 16. Young EJ. Serologic diagnosis of human brucellosis: analysis of 214 cases by agglutination tests and review of the literature. Rev Infect Dis. 1991; 13(3): 359-72[PubMed]
  • 17. Araj GF. Human brucellosis: a classical infectious disease with persistent diagnostic challenges. Clin Lab Sci. 1999; 12(4): 207-12[PubMed]
  • 18. Fakhar M, Banimostafavi E, Motazedian MH, Asgari Q. Co-infection of Leishmania infantum and <italic>Brucella</italic> spp. in Iran. Comp Clin Pathol . 2009; 18(1): 93-4
  • 19. Rezaee MA, Rashidi A, Motaharinia Y, Hossaini W, Rahmani MR. Seroprevalence study of brucellosis among high-risk groups in comparison with other people of the population in Sanandaj (West of Iran). Afr J Microbiol Res. 2012; 6(9): 1985-9[DOI]
  • 20. Abdollahi A, Morteza A, Khalilzadeh O, Rasoulinejad M. Brucellosis serology in HIV-infected patients. Int J Infect Dis. 2010; 14(10)-6[DOI][PubMed]
  • 21. Moreno S, Ariza J, Espinosa FJ, Podzamczer D, Miro JM, Rivero A, et al. Brucellosis in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis. 1998; 17(5): 319-26[PubMed]
  • 22. Akhvlediani T, Clark DV, Chubabria G, Zenaishvili O, Hepburn MJ. The changing pattern of human brucellosis: clinical manifestations, epidemiology, and treatment outcomes over three decades in Georgia. BMC Infect Dis. 2010; 10: 346[DOI][PubMed]
  • 23. Ramos TR, Pinheiro Junior JW, Moura Sobrinho PA, Santana VL, Guerra NR, de Melo LE, et al. Epidemiological aspects of an infection by <italic>Brucella</italic> abortus in risk occupational groups in the microregion of Araguaina, Tocantins. Braz J Infect Dis. 2008; 12(2): 133-8[PubMed]
  • 24. Araj GF, Azzam RA. Seroprevalence of <italic>brucella</italic> antibodies among persons in high-risk occupation in Lebanon. Epidemiol Infect. 1996; 117(2): 281-8[PubMed]
  • 25. Swai ES, Schoonman L. Human brucellosis: seroprevalence and risk factors related to high risk occupational groups in Tanga Municipality, Tanzania. Zoonoses Public Health. 2009; 56(4): 183-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments